Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Vieta

Showing results (71-80 of 259) with videos related to

Pageof 26
Sort By:
Clinical Therapeutics|June 27, 2000
Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con OlanzapinaJ A Sacristán, J C Gómez, A L Montejo, et al.
Acta Psychiatrica Scandinavica|May 25, 2012
Anxiety as a marker of severity in acute maniaA González-Pinto, J Galán, M Martín-Carrasco, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 14, 2011
What we know and what we don't know about the treatment of schizoaffective disorderA Murru, I Pacchiarotti, A M A Nivoli, et al.
Journal of Psychopharmacology (Oxford, England)|December 17, 2008
Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced studyE Vieta, T Ramey, D Keller, et al.
Journal of Affective Disorders|June 19, 2010
Functioning and symptomatic outcomes in patients with bipolar I disorder in syndromal remission: a 1-year, prospective, observational cohort studyA Montoya, M Tohen, E Vieta, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 20, 2010
2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recoveryJ M Haro, C Reed, A Gonzalez-Pinto, et al.
Acta Psychiatrica Scandinavica|February 6, 2013
The bipolar-borderline personality disorders connection in major depressive patientsG Perugi, J Angst, J-M Azorin, et al.
The Journal of Nervous and Mental Disease|June 1, 1997
Suicidal behavior in bipolar I and bipolar II disorderE Vieta, A Benabarre, F Colom, et al.
Human Genetics|November 3, 1998
Variability in the serotonin transporter gene and increased risk for major depression with melancholiaB Gutiérrez, L Pintor, C Gastó, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 4, 2021
Quality of care in psychiatry is related to research activityJ de Arriba-Enriquez, E Sanz-Casado, E Vieta, et al.
Pageof 26

Showing results (71-80 of 259) with videos related to

Sort By:
Pageof 26
Clinical Therapeutics|June 27, 2000
Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con OlanzapinaJ A Sacristán, J C Gómez, A L Montejo, et al.
Acta Psychiatrica Scandinavica|May 25, 2012
Anxiety as a marker of severity in acute maniaA González-Pinto, J Galán, M Martín-Carrasco, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 14, 2011
What we know and what we don't know about the treatment of schizoaffective disorderA Murru, I Pacchiarotti, A M A Nivoli, et al.
Journal of Psychopharmacology (Oxford, England)|December 17, 2008
Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced studyE Vieta, T Ramey, D Keller, et al.
Journal of Affective Disorders|June 19, 2010
Functioning and symptomatic outcomes in patients with bipolar I disorder in syndromal remission: a 1-year, prospective, observational cohort studyA Montoya, M Tohen, E Vieta, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 20, 2010
2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recoveryJ M Haro, C Reed, A Gonzalez-Pinto, et al.
Acta Psychiatrica Scandinavica|February 6, 2013
The bipolar-borderline personality disorders connection in major depressive patientsG Perugi, J Angst, J-M Azorin, et al.
The Journal of Nervous and Mental Disease|June 1, 1997
Suicidal behavior in bipolar I and bipolar II disorderE Vieta, A Benabarre, F Colom, et al.
Human Genetics|November 3, 1998
Variability in the serotonin transporter gene and increased risk for major depression with melancholiaB Gutiérrez, L Pintor, C Gastó, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 4, 2021
Quality of care in psychiatry is related to research activityJ de Arriba-Enriquez, E Sanz-Casado, E Vieta, et al.
Pageof 26